Highly accomplished Pricing & Market Access expert with significant experience in launch pricing strategy, P&R plans, cross-indication strategy, value proposition development, global commercial opportunity and country-level implementation strategies
Deep knowledge of US (Medicare & Medicaid) and EU payer market systems, and conducting primary research with payers and other key stakeholders in these markets
Select your region & language
Our content and services may vary by location.
)
)
Overview
- Availability
- Asap, 5 days/week, on-site & remote
- Qualification
- Ph. D. Biology
- Language Skills
- German (native), English (business fluent)
- Relevant Expertise
- Pricing & Market Access, Launch Pricing Strategies, Reimbursement Strategies, US & EU Market, Cross-Indication Strategies, Project Management, Biotech, Pharma, Rare & Ultra-Rare Diseases
Key-Facts
Extract from previous activities
Pharmaceutical Company, Germany
Market Access Manager
Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)
Strategic market access options development, including a list of contracting options, for cystic fibrosis to drive commercial planning activities
Pharmaceutical Company, Germany
Pricing & Market Access Manager
C Global P&MA strategy for a novel gene therapy in hemophilia B (US, EU5, Brazil & Japan)
Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)
Pharmaceutical Company, Germany
Market Access Manager
Strategic market access options development, including a menu of contracting options, for cystic fibrosis to drive commercial planning activities
Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)
Pricing & Market Access Consultant
Pricing & Market Access Consultant
Managed over 50 EU-based and global projects focused on pricing & market access strategy for tier 1 pharmaceutical companies
Developed expert knowledge of US and EU markets and experienced working with payers across US, CA, EU, LATAM and APAC